Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Autologous Stem Cells Utilized in Phase II Clinical Trial to Treat Multiple Myeloma

Posted by pamela@stemsave.com on Nov 8, 2012 5:00:27 AM

Researchers at the Virginia Commonwealth University’s Masey Cancer Center have developed an innovative approach to the treatment of multiple myeloma. The Phase II Clinical trial involves a process to ‘mark’ cancerous cells and also boost the body’s immune system – by removing the patient’s stem cells, manipulating them in-vitro [outside the body] and then reintroducing the stem cells back into the patient - to destroy the cancerous cells. Researchers believe the reprogrammed stem cells will also prevent any future recurrence of multiple myeloma.

Read More

Topics: stemsaveblog, clinical trials, multiple myeloma, Phase II, Stemcells

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all